These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 36848656

  • 1. Long-Term Changes in the Size of Pituitary Microadenomas.
    Hordejuk D, Cheung YM, Wang W, Smith T, Laws E, Kaiser UB, Min L.
    Ann Intern Med; 2023 Mar; 176(3):298-302. PubMed ID: 36848656
    [Abstract] [Full Text] [Related]

  • 2. Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience.
    Thaker VV, Lage AE, Kumari G, Silvera VM, Cohen LE.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):5906-5912. PubMed ID: 31390015
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of subtraction images for accurate diagnosis of pituitary microadenomas in dynamic contrast-enhanced magnetic resonance imaging.
    Taheri MS, Ghomi Z, Mirshahi R, Moradpour M, Niroomand M, Yarmohamadi P, Zeidabadi H.
    Acta Radiol; 2023 Mar 01; 64(3):1148-1154. PubMed ID: 35731731
    [Abstract] [Full Text] [Related]

  • 4. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP, Patronas N, Smirniotopoulos JG, Piazza M, Benzo S, Ray-Chaudhury A, Sharma S, Lodish M, Nieman L, Stratakis CA, Chittiboina P.
    J Neurosurg; 2018 Sep 01; 129(3):620-628. PubMed ID: 29027863
    [Abstract] [Full Text] [Related]

  • 5. Contrast-enhanced 3D-T2-weighted SPACE sequence for MRI detection and localization of adrenocorticotropin (ACTH)-secreting pituitary microadenomas.
    Wu Y, Cai Y, Rui W, Tang Y, Yang Z, He M, Ye H, Wang Y, Zhao Y, Ma Z, Yao Z.
    Clin Endocrinol (Oxf); 2022 Apr 01; 96(4):578-588. PubMed ID: 34323314
    [Abstract] [Full Text] [Related]

  • 6. Ultra-High-Field 7 T Magnetic Resonance Imaging Including Dynamic and Static Contrast-Enhanced T1-Weighted Imaging Improves Detection of Secreting Pituitary Microadenomas.
    Eisenhut F, Schlaffer SM, Hock S, Heynold E, Kremenevski N, Bluemcke I, Buchfelder M, Doerfler A, Schmidt MA.
    Invest Radiol; 2022 Sep 01; 57(9):567-574. PubMed ID: 35925660
    [Abstract] [Full Text] [Related]

  • 7. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH.
    J Neurosurg; 2018 Apr 01; 128(4):1051-1057. PubMed ID: 28452619
    [Abstract] [Full Text] [Related]

  • 8. Pituitary magnetic resonance imaging in Cushing's disease.
    Vitale G, Tortora F, Baldelli R, Cocchiara F, Paragliola RM, Sbardella E, Simeoli C, Caranci F, Pivonello R, Colao A, A.B.C. Group.
    Endocrine; 2017 Mar 01; 55(3):691-696. PubMed ID: 27435590
    [Abstract] [Full Text] [Related]

  • 9. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.
    Salenave S, Gatta B, Pecheur S, San-Galli F, Visot A, Lasjaunias P, Roger P, Berge J, Young J, Tabarin A, Chanson P.
    J Clin Endocrinol Metab; 2004 Jul 01; 89(7):3371-6. PubMed ID: 15240617
    [Abstract] [Full Text] [Related]

  • 10. [MRI: incidence and evaluation of size and form criteria in hypophysis-healthy probands and in patients with detectable microadenomas].
    Dietrich CF, Kirchner J, Higer P, Heyd R, Berkefeld J.
    Aktuelle Radiol; 1997 May 01; 7(3):130-4. PubMed ID: 9296607
    [Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
    Tabarin A, Laurent F, Catargi B, Olivier-Puel F, Lescene R, Berge J, Galli FS, Drouillard J, Roger P, Guerin J.
    Clin Endocrinol (Oxf); 1998 Sep 01; 49(3):293-300. PubMed ID: 9861318
    [Abstract] [Full Text] [Related]

  • 12. Clinically Nonfunctioning Pituitary Incidentalomas: Characteristics and Natural History.
    Tresoldi AS, Carosi G, Betella N, Del Sindaco G, Indirli R, Ferrante E, Sala E, Giavoli C, Morenghi E, Locatelli M, Milani D, Mazziotti G, Spada A, Arosio M, Mantovani G, Lania AGA.
    Neuroendocrinology; 2020 Sep 01; 110(7-8):595-603. PubMed ID: 31525736
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 01; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 14. Application of Contrast-Enhanced 3-Dimensional T2-Weighted Volume Isotropic Turbo Spin Echo Acquisition Sequence in the Diagnosis of Prolactin-Secreting Pituitary Microadenomas.
    Guo R, Wu Y, Guo G, Zhou H, Liu S, Yao Z, Xiao Y.
    J Comput Assist Tomogr; 2014 Dec 01; 46(1):116-123. PubMed ID: 35099143
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively.
    Sam AH, Shah S, Saleh K, Joshi J, Roncaroli F, Robinson S, Cox J, Martin NM, Mendoza N, Meeran K, Mehta A, Dhillo WS.
    Clin Endocrinol (Oxf); 2015 Dec 01; 83(6):861-5. PubMed ID: 26201671
    [Abstract] [Full Text] [Related]

  • 16. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 01; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 17. Nonfunctioning Pituitary Microadenomas: Should Imaging Interval be Extended? A Large Single-center Cohort Study.
    Han AJ, Varlamov EV, Fleseriu M.
    J Clin Endocrinol Metab; 2022 Feb 17; 107(3):e1231-e1241. PubMed ID: 34648635
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.
    Fukuhara N, Inoshita N, Yamaguchi-Okada M, Tatsushima K, Takeshita A, Ito J, Takeuchi Y, Yamada S, Nishioka H.
    Endocr J; 2019 Mar 28; 66(3):259-264. PubMed ID: 30760659
    [Abstract] [Full Text] [Related]

  • 19. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P, Montgomery BK, Millo C, Herscovitch P, Lonser RR.
    J Neurosurg; 2015 Apr 28; 122(4):791-7. PubMed ID: 25479121
    [Abstract] [Full Text] [Related]

  • 20. Pituitary incidentaloma.
    Constantinescu SM, Maiter D.
    Presse Med; 2021 Dec 28; 50(4):104081. PubMed ID: 34687911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.